The Carlyle Group Inc. (CG) Competitors & Peers
The 5 largest companies in the same industry as The Carlyle Group Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| BLK | Peer | $1,178.87 | P/E 26.8RSI 58Cap 182.6 B |
| BX | Peer | $119.50 | P/E 26.6RSI 53Cap 95.6 B |
| BN | Peer | $41.38 | P/E 76.6RSI 63Cap 92.4 B |
| KKR | Competitor | $96.48 | P/E 30.8RSI 54Cap 86.6 B |
| BAM | Peer | $52.95 | P/E 17.9RSI 69Cap 84.6 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- KKRCompetitor
Top PE shops.
Model-inferred, unverified — treat as a lead, not evidence - BAXSupplier
Carlyle acquired Vantive (Baxter Kidney Care) for $3.8B.
Model-inferred, unverified — treat as a lead, not evidence - APOCompetitor
Top PE shops.
Model-inferred, unverified — treat as a lead, not evidence